146 related articles for article (PubMed ID: 29183231)
1. In silico prediction of multiple-category classification model for cytochrome P450 inhibitors and non-inhibitors using machine-learning method.
Lee JH; Basith S; Cui M; Kim B; Choi S
SAR QSAR Environ Res; 2017 Oct; 28(10):863-874. PubMed ID: 29183231
[TBL] [Abstract][Full Text] [Related]
2. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
[TBL] [Abstract][Full Text] [Related]
3. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes.
Plonka W; Stork C; Šícho M; Kirchmair J
Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network.
Li X; Xu Y; Lai L; Pei J
Mol Pharm; 2018 Oct; 15(10):4336-4345. PubMed ID: 29775322
[TBL] [Abstract][Full Text] [Related]
5. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
[TBL] [Abstract][Full Text] [Related]
6. iCYP-MFE: Identifying Human Cytochrome P450 Inhibitors Using Multitask Learning and Molecular Fingerprint-Embedded Encoding.
Nguyen-Vo TH; Trinh QH; Nguyen L; Nguyen-Hoang PU; Nguyen TN; Nguyen DT; Nguyen BP; Le L
J Chem Inf Model; 2022 Nov; 62(21):5059-5068. PubMed ID: 34672553
[TBL] [Abstract][Full Text] [Related]
7. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
[TBL] [Abstract][Full Text] [Related]
8. Computational prediction of cytochrome P450 inhibition and induction.
Kato H
Drug Metab Pharmacokinet; 2020 Feb; 35(1):30-44. PubMed ID: 31902468
[TBL] [Abstract][Full Text] [Related]
9. Rule-Based Prediction Models of Cytochrome P450 Inhibition.
Su BH; Tu YS; Lin C; Shao CY; Lin OA; Tseng YJ
J Chem Inf Model; 2015 Jul; 55(7):1426-34. PubMed ID: 26108525
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.
Mishra NK; Agarwal S; Raghava GP
BMC Pharmacol; 2010 Jul; 10():8. PubMed ID: 20637097
[TBL] [Abstract][Full Text] [Related]
11. In silico classification of adenosine receptor antagonists using Laplacian-modified naïve Bayesian, support vector machine, and recursive partitioning.
Lee JH; Lee S; Choi S
J Mol Graph Model; 2010 Jun; 28(8):883-90. PubMed ID: 20447849
[TBL] [Abstract][Full Text] [Related]
12. In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9.
Nembri S; Grisoni F; Consonni V; Todeschini R
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294921
[TBL] [Abstract][Full Text] [Related]
13. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
[TBL] [Abstract][Full Text] [Related]
14. Computational models for predicting interactions with cytochrome p450 enzyme.
Arimoto R
Curr Top Med Chem; 2006; 6(15):1609-18. PubMed ID: 16918472
[TBL] [Abstract][Full Text] [Related]
15. Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity.
Zhang T; Dai H; Liu LA; Lewis DF; Wei D
Mol Inform; 2012 Jan; 31(1):53-62. PubMed ID: 27478177
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.
Giri P; Naidu S; Patel N; Patel H; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934
[TBL] [Abstract][Full Text] [Related]
17. CYPstrate: A Set of Machine Learning Models for the Accurate Classification of Cytochrome P450 Enzyme Substrates and Non-Substrates.
Holmer M; de Bruyn Kops C; Stork C; Kirchmair J
Molecules; 2021 Aug; 26(15):. PubMed ID: 34361831
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance.
Iga K
J Pharm Sci; 2016 Mar; 105(3):1307-17. PubMed ID: 26886336
[TBL] [Abstract][Full Text] [Related]
19. FAME 2: Simple and Effective Machine Learning Model of Cytochrome P450 Regioselectivity.
Šícho M; de Bruyn Kops C; Stork C; Svozil D; Kirchmair J
J Chem Inf Model; 2017 Aug; 57(8):1832-1846. PubMed ID: 28782945
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.
Gong C; Feng Y; Zhu J; Liu G; Tang Y; Li W
J Appl Toxicol; 2024 Mar; ():. PubMed ID: 38544296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
